SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Bioterrorism -- Ignore unavailable to you. Want to Upgrade?


To: BulbaMan who wrote (241)10/15/2001 7:49:00 AM
From: GARY P GROBBEL  Read Replies (1) | Respond to of 891
 
When it comes to air and filtering same you may want to look at EMFP (OTC BB .59) ...first, description from 10-k, then last qtrs results where sales increased substantially BEFORE 9/11:

10-k:
The Company's management is now completing transformation from a
technology-driven research and development business to a marketing-driven
proprietary products company. Product development efforts remain an important
priority, but are now balanced by an increasing focus on elements of production
and sales.

The Company's current product line includes:

- RespAide(TM) CPR Isolation Mask. The company has received Federal
Drug Administration ("FDA") approval for its RespAide (TM) CPR
isolation mask incorporating the VIV filter, and recently commenced
volume manufacturing and distribution of complete units and
replacement filters (the RespAide(TM) filter needs to be replaced
after each use). In tests by Nelson Laboratories, RespAide(TM) was
found to be greater than 99.9% effective against bacterial and viral
transmission -- the highest rating testing labs will issue for
medical devices, and believed by management of the Company to be
superior to any competing product on the market.

- Disposable Filters for BVMs. The same filter used in the RespAide(TM)
product is ideal for preventing contamination of "bag valve masks",
which are single-use ventilators. The disposable filter keeps the
equipment contaminant-free, thereby allowing a BVM to be safely
reused with a new filter -- a considerable economic benefit due to
the lower replacement and disposal costs of the filter versus
discarding the entire BVM unit. The Company has applied for FDA
approval.

- Ventilator Circuits. To extend its market reach from emergency
response sites to the vast number of respiratory procedures conducted
within medical facilities, the Company has introduced two new
configurations of its VIV technology: (1) a one-way ventilator
circuit that eliminates the exhalation ports of patient's breath in
favor of permitting a T-valve attachment of monitoring CO2 levels --
suitable for any inline ventilator connection; and (2) a two-way
ventilator circuit for applications where ambient air flow must pass
evenly in both directions while still protecting equipment and hoses.
This is suitable for use in anesthesia and general respiratory
procedures. The company has applied for FDA approval.

In addition, the Company is developing another configuration of
the technology for the BVM market that incorporates a self-contained nebulizer,
a filter, and a bag with built-in CO2 monitoring capabilities. A patent has been
granted for this product and the Company has executed an agreement whereby it
acquired the rights for commercial exploitation of the patent. The Company is
currently conducting prototype development.

The market for air purification filters for protection against
communicable diseases has grown rapidly since the mid-1980's - from practically
nil,

to an estimated 1,460,000,000 in 1997. Demand has been driven largely by such
factors as the spread of AIDS and Hepatitis C, the resurgence of Tuberculosis in
many urban settings, and growing concerns in the medical community about new
drug-resistant strains of bacteria. Such concerns are clearly evident in the
results of recent independent surveys indicating that approximately 45% of
doctors, 57% of EMTs, 80% of nurses, and substantially all paramedics surveyed
would refuse to perform mouth-to-mouth resuscitation on an adult stranger
without barrier protection. Indeed, many of the respondents indicated that they
had already walked away from situations in the community requiring
mouth-to-mouth resuscitation.

In addition to emergency ambulance services, police departments,
firefighters, hospitals, doctors, the military, and major CPR training
organizations such as the American Heart Association, management believes that
the market also includes government and private sector entities that will
choose, or may be required by law to keep CPR isolation masks on hand.

The Company currently holds military national stocking numbers
for the RespAide(TM) CPR isolation mask and replacement filters. These stocking
numbers make both products acceptable for inventory in all four branches of the
military and the U.S. Coast Guard. The Company received and fulfilled orders
from the Defense Supply Center Philadelphia for the RespAide(TM) device and its
replacement parts in the fourth quarter of 2000 which account for a significant
percentage of sales for the fiscal year.

To reach the market, the Company has entered into contractual
arrangements with a number of U.S. and international medical product
distributors. Additionally, the Company is actively pursuing licensing
agreements with other companies that have market penetration.

The Company intends to firmly establish its reputation for
supplying the best medical air filters available, and then begin aggressively
commercializing the technology in the enormous HVAC category. The Company
estimates that the addition of HVAC applications will increase the total
addressable market for dual-filtered (2H) technology.

Last qtr:
(COMTEX) B: EMERGENCY FILTRATION PRODUCTS INC - Second Quarter Results
B: EMERGENCY FILTRATION PRODUCTS INC - Second Quarter Results

New York, New York, Aug 22, 2001 (Market News Publishing via COMTEX) --
Emergency Filtration Products Inc. ("EFP" or "the company") announced its second
quarter results.

During the quarter, the company made significant progress in sales growth and
appreciably reduced its losses.

Compared with the same quarter last year, sales increased nineteenfold, from
$13,532 to $260,122, due to the company's transition from a research orientation
to a much more marketing-driven organization. Expenses grew a slight 1.6
percent, from $343,725 to $349,568. Losses were reduced by 72 percent, from
$340,434 to $93,510. Loss per share decreased from 4 cents to 1 cent.

Compared with the six months ended June 30, sales increased 22 times, to
$421,852; expenses decreased 26 percent, to $672,089; and net losses were
reduced by 69 percent, to $258,487. Loss per share decreased from 10 cents to 2
cents.

EFP founder and chief technology officer, Doug Beplate, commented: "The past
nine months have seen the beginnings of the company's growth. We believe the
second half of 2001 will surpass the first by a noticeable margin. During this
period we expect to ship orders totaling approximately $1 million, with the
majority of those sales in the fourth quarter."

The company intends to increase growth by introducing new products and
implementing a marketing program, the initial impetus of which will be toward
building a network of 20 to 25 distributors.

Thereafter, a national network of sales representatives will be established. To
date, the majority of sales have been internally generated, with only a small
amount of product being sold through distributors.

The company believes the increased availability and visibility gained through
distributors will have a dramatic effect on net sales beginning in the first
quarter of 2002.

About Emergency Filtration Products Inc.:

EFP is a filtration company based upon its proprietary 2H(TM) technology which
combines hydrophilic (moisture absorbent) and hydrophobic (moisture repellent)
filter media. Together, these materials create filter efficiencies of greater
than 99.99 percent at a particle size of 0.027 microns according to independent
laboratory tests.

Safe Harbor Statement: This news release contains forward-looking statements
pursuant to the "Safe Harbor" provisions of the Private Securities Litigation
Reform Act of 1995. With the exception of historical information, the matters
discussed in this news release are "forward-looking statements" that involve a
number of risks and uncertainties. The actual future results of the company
could differ significantly from those statements.


CONTACT: TEL: 800/380-7669 Emergency Filtration Products Inc.
FAX: 702/269-6253 Sterling Petersen
EMAIL: stpetie@flash.net

MarketbyFax(tm) - To get the NEWS as it happens, call (604) 689-3041.

(C) 2001 Market News Publishing Inc.

-0-


KEYWORD: New York, New York

*** end of story ***



To: BulbaMan who wrote (241)10/15/2001 9:18:57 AM
From: scaram(o)uche  Respond to of 891
 
I think that both of these companies are private? However, there are others that produce biosafety cabinets, I just can't think of them at the moment..........

nuaire.com

bakerco.com